Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG for Autoimmune Small Fiber Neuropathy
NCT03401073Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Sep 2018
- Primary completion
- Feb 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of intravenous immunoglobulin G in small fiber neuropathy (SFN), sponsored by Beth Israel Deaconess Medical Center. Started Sep 2018; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
small fiber neuropathy (SFN)
Beyond the preview
Go deeper on NCT03401073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03401073.